Clin2
NCT05532566Possibly a fitRecruiting

Tested oak tree allergy extracts for people with inhalant allergy

Allergic ReactionAllergic Skin ReactionAllergy Pollen

Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.

This trial studies how well standardized oak (Quercus ilex and Quercus robur) allergen extracts match your specific allergy. It may help refine allergy testing and treatment planning for people with oak-triggered rhinitis, eye symptoms, and/or asthma.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You are 18 to 64 years old and can give informed consent.
  • Your allergy symptoms include breathing-related allergies triggered by oak trees (nose and/or eyes and/or asthma).
  • Your test results show you likely react to oak: a positive skin prick test (or specific blood allergy antibodies).
  • You meet skin-test response targets (your skin reaction size must meet minimum thresholds).
  • You do not have pregnancy, and you are not breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04891237Recruiting· Phase 3
Grass and olive allergy vaccine trial for teens to older adults

This Phase 3 trial tests whether an allergy treatment can reduce symptoms caused by grass and olive pollen. It also checks safety, especially for breathing and allergic reactions, in people with confirmed grass/olive allergy.

Tarancón, Cuenca
NCT04898283Recruiting· Phase 3
Allergy shot study for grass and cypress pollen symptoms

This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.

Valladolid, Castille and León
NCT05042830Recruiting
Tests how birch allergy in the nose affects allergy signals in blood

This study looks at people with a birch pollen allergy to see how exposure in the nose can change allergy-related blood signals. The results may help explain why symptoms can “boost” throughout the body after nasal allergen contact.

Vienna, State of Vienna
NCT07348302Recruiting· Phase 3
Allergy tablet for dust mite rhinitis and asthma

This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.

Nueve de Julio, Buenos Aires
NCT05521711Recruiting
Testing an at-home route for tree nut allergy immunotherapy

This study tests how a specific form of treatment is given to people with a tree nut allergy. The goal is to find a safer, more effective way to help your body tolerate tree nuts.

Hamilton, Ontario
NCT06771791Recruiting· Phase 3
Apple oral immunotherapy trial for birch pollen and apple allergy

This trial tests if eating small amounts of raw apple can help people with birch pollen allergy who also have mouth itching or swelling from apples. You will be given gradually increasing doses of apple to see if your allergy improves.

Strasbourg, France

Hear when a new Allergic Reaction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.